Back

Etiology-specific outcomes in refractory cardiogenic shock treated with Impella 2.5/CP: a 8-year real-world cohort

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Cardiogenic shock, extracorporeal membrane oxygenation, and perfusion technology Circulatory Support ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Fares Kano

University Heart Centre, Philipps University Marburg, Marburg (Germany)

5 More presentations in this session

Presentation thumbnail
Vasoplegic syndrome after cardiopulmonary bypass: prevalence, predictors, and outcomes in a Mexican cardiac surgery cohort
Doctor J. Caceres Medina (Mexico City, MX)
Abstract Slides Video
Presentation thumbnail
Early left ventricular unloading with intra-aortic balloon pump versus micro-axial flow pump in cardiogenic shock supported by VA-ECMO: an international observational target trial emulation
Doctor A. Ughetto (FR)
Abstract Slides Video
Presentation thumbnail
Hemoadsorption during VA-ECMO: results from the international prospective COSMOS registry
Doctor J. Kreutz (Marburg, DE)
Abstract Slides Video
Presentation thumbnail
First-in-human experience with Tulyp: a novel extracorporeal perfusion system for acute limb ischemia
Mr T. Lenihan (Paris, GF)
Abstract Slides Video
Presentation thumbnail
Comparative outcomes of extrathoracic, intrathoracic and facilitated transfemoral access for transcatheter aortic valve implantation: a systematic review and meta-analysis
Doctor A. Zaka (Southport, AU)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiogenic shock, extracorporeal membrane oxygenation, and perfusion technology

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Bloodstream infections during Impella support in refractory cardiogenic shock: incidence, microbiology and clinical implications
29 August 2026
thumbnail
Congress Presentation
Epidemiology, health care burden and organisation of treatment
23 May 2023
thumbnail
Congress Presentation
Clinical predictors of in-hospital mortality in adult patients with refractory cardiogenic shock or cardiac arrest supported with veno-arterial extracorporeal membrane oxygenation
31 August 2026
thumbnail
Congress Presentation
Acute myocardial infarction (AMI) vs. Non-AMI cardiogenic shock treated with microaxial flow pump support: insights from the multicenter MMERGE registry
30 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources